Background: Obesity may be a risk factor for developing multiple sclerosis (MS). Objective: We examined if body size influences the risk of MS in a population-based, case control study. Methods: A total of 953 cases and 1717 controls from Norway and 707 cases and 1333 controls from Italy reported their body size by choosing a silhouette 1 to 9 (largest) every fifth year from age 5 to 30 and at time of study. The body size-related MS risk was defined by odds ratios (ORs) in logistic regression analyses adjusting for age, smoking and outdoor activity. Results: In Norway a large body size (silhouettes 69) compared to silhouette 3 increased the risk of MS, especially at age 25 (OR 2.21; 95% CI 1.094.46 for men and OR 1.43; 95% CI 0.902.27 for women). When comparing silhouette 9 to 1, we found a significant dose-response from age 10 until age 30 peaking at age 25 (sex-adjusted OR 2.83; 95% CI 1.684.78). The association was present for at least 15 years prior to disease onset. No significant associations were found in Italy. Conclusions: Obesity from childhood until young adulthood is a likely risk factor for MS with a seemingly stronger effect in Norway than in Italy.

Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study

CASETTA, Ilaria;GRANIERI, Enrico Gavino Giuseppe;PUGLIATTI, Maura;
2015

Abstract

Background: Obesity may be a risk factor for developing multiple sclerosis (MS). Objective: We examined if body size influences the risk of MS in a population-based, case control study. Methods: A total of 953 cases and 1717 controls from Norway and 707 cases and 1333 controls from Italy reported their body size by choosing a silhouette 1 to 9 (largest) every fifth year from age 5 to 30 and at time of study. The body size-related MS risk was defined by odds ratios (ORs) in logistic regression analyses adjusting for age, smoking and outdoor activity. Results: In Norway a large body size (silhouettes 69) compared to silhouette 3 increased the risk of MS, especially at age 25 (OR 2.21; 95% CI 1.094.46 for men and OR 1.43; 95% CI 0.902.27 for women). When comparing silhouette 9 to 1, we found a significant dose-response from age 10 until age 30 peaking at age 25 (sex-adjusted OR 2.83; 95% CI 1.684.78). The association was present for at least 15 years prior to disease onset. No significant associations were found in Italy. Conclusions: Obesity from childhood until young adulthood is a likely risk factor for MS with a seemingly stronger effect in Norway than in Italy.
2015
Wesnes, K; Riise, T; Casetta, Ilaria; Drulovic, J; Granieri, Enrico Gavino Giuseppe; Holmøy, T; Kampman, Mt; Landtblom, Am; Lauer, K; Lossius, A; Maga...espandi
File in questo prodotto:
File Dimensione Formato  
11392_2122212.pdf

solo gestori archivio

Descrizione: Full text ahead of print/Version of Record
Tipologia: Full text (versione editoriale)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 991.64 kB
Formato Adobe PDF
991.64 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
11392_2122212bis.pdf

accesso aperto

Descrizione: Pre print
Tipologia: Pre-print
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 654.63 kB
Formato Adobe PDF
654.63 kB Adobe PDF Visualizza/Apri

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2122212
Citazioni
  • ???jsp.display-item.citation.pmc??? 30
  • Scopus 81
  • ???jsp.display-item.citation.isi??? 78
social impact